This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

Hurry! $500 Savings Ends In:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
December 4 - 8, 2022
Marriott Marquis San DiegoDelivered as a Hybrid Event

Jeff Allen, Ph.D.
Vice President, Protein Sciences at Pelican Expression Technology

Profile

Jeff Allen, PhD was a founding member of the Pelican team responsible for analytical development, detailed protein product characterization, downstream processing, and regulatory CMC to support internal and partnered programs. Now with Ligand, Dr. Allen supports current and new partnerships and collaborations for Pelican Expression Technology™, providing scientific oversight and input to the continued growth, innovation, and technical assessment of new opportunities. Dr. Allen has more than 25 years of experience in protein biochemistry having held positions as R&D Leader of Analytical Biochemistry and Senior R&D Biochemist at DowPharma, a business within The Dow Chemical Company, prior to forming Pfenex in 2009. He joined Dow in 1999 where his main responsibilities included R&D support in Dow’s Human Health and Diagnostics platform. Dr. Allen has authored and contributed to multiple publications, presentations, global regulatory filings, and patents and holds a PhD in Biochemistry from Utah State University, and a Bachelor of Science Degree in Molecular Biology from the University of Wisconsin-Madison.

Agenda Sessions

  • Process Development and Detailed Analytical Characterization of PicobodiesTM: a Novel Antibody Format Produced using Pelican Expression TechnologyTM

    1:45pm